UMIN000052532

Clinical pharmacological test of calcium alginate capsules -Optimization study of postprandial serum triglyceride elevation suppression effect (additional preliminary study)-

Takasaki University of Health and Welfare·University Hospital Medical Information Network·dietary supplementNot yet recruiting
Study focus
Disease/Condition
Healthy subjects
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Takasaki University of Health and Welfare
Location
Japan
Timeline & enrollment
Phase
N/A
Start date
Oct 20, 2023
End date
N/A
ICD-10 classifications
Occupational health examinationSeeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulRoutine child health examinationExamination and observation for other reasons
Data source
Registry
University Hospital Medical Information Network
Trial ID
UMIN000052532
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for UMIN000052532 through Pure Global AI's free database. This phase not specified trial is sponsored by Takasaki University of Health and Welfare and is currently Not yet recruiting. The study focuses on Healthy subjects.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.